These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20055107)

  • 1. Development and evaluation of nitrendipine nanoemulsion for intranasal delivery.
    Jain R; Patravale VB
    J Biomed Nanotechnol; 2009 Feb; 5(1):62-8. PubMed ID: 20055107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.
    Sharma A; Singh AP; Harikumar SL
    Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777
    [No Abstract]   [Full Text] [Related]  

  • 3. Quetiapine Nanoemulsion for Intranasal Drug Delivery: Evaluation of Brain-Targeting Efficiency.
    Boche M; Pokharkar V
    AAPS PharmSciTech; 2017 Apr; 18(3):686-696. PubMed ID: 27207184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D.
    Ke Z; Hou X; Jia XB
    Drug Des Devel Ther; 2016; 10():2049-60. PubMed ID: 27418807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoemulsifying drug delivery system to improve the bioavailability of piroxicam.
    Motawea A; Borg T; Tarshoby M; Abd El-Gawad AE
    Pharm Dev Technol; 2017 May; 22(3):445-456. PubMed ID: 27583581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of udenafil-loaded microemulsions for intranasal delivery: in vitro and in vivo evaluations.
    Cho HJ; Ku WS; Termsarasab U; Yoon I; Chung CW; Moon HT; Kim DD
    Int J Pharm; 2012 Feb; 423(2):153-60. PubMed ID: 22209996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality by design approach for oral bioavailability enhancement of irbesartan by self-nanoemulsifying tablets.
    Patel J; Dhingani A; Garala K; Raval M; Sheth N
    Drug Deliv; 2014 Sep; 21(6):412-35. PubMed ID: 24215334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Targeted Intranasal Zaleplon Nano-emulsion: In-Vitro Characterization and Assessment of Gamma Aminobutyric Acid Levels in Rabbits' Brain and Plasma at Low and High Doses.
    Abd-Elrasheed E; El-Helaly SN; El-Ashmoony MM; Salah S
    Curr Drug Deliv; 2018; 15(6):898-906. PubMed ID: 29189154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.
    Kumar VV; Chandrasekar D; Ramakrishna S; Kishan V; Rao YM; Diwan PV
    Int J Pharm; 2007 Apr; 335(1-2):167-175. PubMed ID: 17161566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration.
    Manjunath K; Venkateswarlu V
    J Drug Target; 2006 Nov; 14(9):632-45. PubMed ID: 17090399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics.
    Bhaskar K; Krishna Mohan C; Lingam M; Jagan Mohan S; Venkateswarlu V; Madhusudan Rao Y; Bhaskar K; Anbu J; Ravichandran V
    Drug Dev Ind Pharm; 2009 Jan; 35(1):98-113. PubMed ID: 18665979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether.
    Laxmi M; Bhardwaj A; Mehta S; Mehta A
    Artif Cells Nanomed Biotechnol; 2015; 43(5):334-44. PubMed ID: 24641773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of oral nanoemulsion drug delivery system of mebudipine.
    Khani S; Keyhanfar F; Amani A
    Drug Deliv; 2016 Jul; 23(6):2035-43. PubMed ID: 26406153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
    Patel N; Nakrani H; Raval M; Sheth N
    Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an ethyl laurate-based microemulsion for rapid-onset intranasal delivery of diazepam.
    Li L; Nandi I; Kim KH
    Int J Pharm; 2002 Apr; 237(1-2):77-85. PubMed ID: 11955806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal in situ gel loaded with saquinavir mesylate nanosized microemulsion: preparation, characterization, and in vivo evaluation.
    Hosny KM; Hassan AH
    Int J Pharm; 2014 Nov; 475(1-2):191-7. PubMed ID: 25178831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress.
    Pangeni R; Sharma S; Mustafa G; Ali J; Baboota S
    Nanotechnology; 2014 Dec; 25(48):485102. PubMed ID: 25392203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoemulsion: for improved oral delivery of repaglinide.
    Akhtar J; Siddiqui HH; Fareed S; Badruddeen ; Khalid M; Aqil M
    Drug Deliv; 2016 Jul; 23(6):2026-34. PubMed ID: 27187792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
    Rajpoot P; Bali V; Pathak K
    Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary studies for the development of intranasal nanoemulsion containing CNS agent: emphasizing the utilization of cut and weigh method.
    Kumar A; Jain SK
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):515-521. PubMed ID: 27007745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.